PULARTER 20 MG FILM COATED TABLET 90 TABLETS

PULARTER NOTCHED FILM COATED TABLET 20 mg

Active ingredient: 28.096 mg sildenafil citrate, equivalent to 20 mg sildenafil

Excipients: Microcrystalline cellulose (RQ 101), Dibasic Calcium Phosphate Dihydrate (Calipharm D), Croscarmellose Sodium (AC-DI-SOL), Hypromellose (Methocel E5), Croscarmellose Sodium (AC-DI-SOL), Magnesium Stearate, Opadry II White 32F58900 [Hypromellose (HPMC) 2910), Lactose Monohydrate (sourced from bovine milk), Titanium Dioxide, Polyethylene Glycol (Macrogol)]

Before you start using this medicine, read this INSTRUCTIONS FOR USE carefully, because it contains important information for you.

Detailed information for this product is available.

Instructions for proper use and dosage/frequency of administration

Tablets are taken orally by swallowing them with a glass of water.

The recommended dose for children and adolescents 1 year to 17 years of age, taken with or without food, is 10 mg three times daily for children and adolescents weighing less than 20 kg or 20 mg three times daily for children and adolescents weighing more than 20 kg. Higher doses should not be used in children. This medication should only be used if given at 20 mg 3 times a day.

Your doctor will not make a special dose adjustment for you.

If you have problems with your kidneys, tell your doctor as the dose may need to be adjusted.

Like all medicines, PULARTER may have side effects in people who are sensitive to its ingredients.

If any of the following side effects occur, stop using PULARTER and contact a physician immediately:

If you observe a side effect that bothers you or notice a side effect not specified in this leaflet, please inform your doctor or pharmacist. Side effects are listed as shown in the categories below.

Very common (>1/10); common (>1/100 to 1/1,000 to 1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data)

In an unknown frequency (frequency cannot be estimated with available data), skin rash, sudden decrease or loss of hearing, low blood pressure, non-vascular optic nerve injury (Non-arthritic anterior ischemic optic neuropathy – NAION), occlusion of the vessels in the retina of the eye and visual field defect have been reported.

⚠️ Disclaimer: Information provided is for educational purposes only. Always consult a healthcare provider.